Loss of RB expression in an ACTH-secreting pituitary carcinoma

Cancer Letters

Volumn 126, Issue 2, 1998, Pages 209-214

  Hinton, David R ^a   Hahn, Jeffrey A ^b   Weiss, Martin H ^c   Couldwell, William T ^d  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b HUNTINGTON MEMORIAL HOSPITAL   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^d NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

Adrenocorticotrophic hormone; Cushing disease; Pituitary adenoma; Pituitary carcinoma; Rb gene

Indexed keywords

CORTICOTROPIN; RETINOBLASTOMA PROTEIN;

ADULT; ARTICLE; BENIGN TUMOR; CANCER GROWTH; CARCINOMA; CASE REPORT; CORTICOTROPIN RELEASE; FEMALE; HUMAN; HUMAN TISSUE; HYPOPHYSIS ADENOMA; HYPOPHYSIS TUMOR; METASTASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR SUPPRESSOR GENE;

ADRENOCORTICOTROPIC HORMONE; CARCINOMA; CUSHING SYNDROME; DISEASE PROGRESSION; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM PROTEINS; PITUITARY NEOPLASMS; RETINOBLASTOMA PROTEIN;

ANIMALIA;

EID: 0031942038     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(98)00013-5     Document Type: Article

References (33)

1. K. Kovacs, E. Horvath, Tumors of the pituitary gland, Atlas of Tumor Pathology, second series, Fascicle 21, Armed Forces Institute of Pathology, Washington, DC, 1986.
2. Pernicone P.J., Scheithauer B.W., Sebo T.J., Kovacs K.T., Horvath E., Young W.F. Jr., Lloyd R.V., Davis D.H., Guthrie B.L., Schoene W.C. Pituitary carcinoma. A clinicopathologic study of 15 cases. Cancer. 79:1997;804-812.
3. Beauchesne P., Trouillas J., Barral F., Brunon J. Gondadotropic pituitary carcinoma: case report. Neurosurgery. 37:1995;810-816.
4. Boggild M.D., Jenkinson S., Pistorello M., Baocaro M., Scanarini M., McTernan P., Perrett C.W., Thakker R.V., Clayton R.N. Molecular genetic studies of sporadic pituitary tumors. J. Clin. Endocrinol. Metab. 78:1994;387-392.
5. Thapar K., Scheithauer B.W., Kovacs K., Pernicone P.J., Laws E.R. Jr. p53 expression in pituitary adenomas and carcinomas: correlation with invasiveness and tumor growth fractions. Neurosurgery. 38:1996;765-771.
6. Spada A., Vallar L., Faglia G. Cellular alterations in pituitary tumors. Eur. J. Endocrinol. 130:1994;43-52.
7. Cai W.Y., Alexander J.M., Hedley-Whyte E.T., Scheithauer B.W., Jameson J.L., Zervas N.T., Klibanski A. ras mutations in human prolactinomas and pituitary carcinomas. J. Clin. Endocrinol. Metab. 78:1994;89-93.
8. Pei L., Melmed S., Scheithauer B., Kovacs K., Prager D. H-ras mutations in human pituitary carcinoma metastases. J. Clin. Endocrinol. Metab. 78:1994;842-846.
9. kip1 expression in nontumorous and neoplastic human pituitaries. Am. J. Pathol. 151:1997;509-519.
10. kip1 gene and trisomy 12 in a subset of human pituitary adenomas. J. Clin. Endocrinol. Metab. 82:1997;3141-3147.
11. Harvey M., Vogel H., Lee E.Y.-H.P., Bradley A., Donehower L.A. Mice deficient in both p53 and Rb develop tumors primarily of endocrine origin. Cancer Res. 55:1995;1146-1151.
12. Δ20/+ mice are predisposed to tumors of the pituitary gland with a nearly complete penetrance. Oncogene. 9:1994;1021-1027.
13. Maandag E.C., van der Lugt N., Vlaar M., Feltkamp C., O'Brien J., van Roon M., van der Lugt N., Berns A., te Riele H. Developmental rescue of an embryonic-lethal mutation in the retinoblastoma gene in chimeric mice. EMBO J. 13:1994;4260-4268.
14. Riley D.J., Lai C.C., Chang C.Y., Jones D., Lee E.Y., Lee W.H. Susceptibility to tumors induced in mice by ethylnitrosurea is independent of retinoblastoma gene dosage. Cancer Res. 54:1994;6097-6101.
15. Williams B.O., Schmitt E.M., Remington L., Bronson R.T., Albert D.M., Weinberg R.A., Jacks T. Extensive contribution of Rb-deficient cells to adult chimeric mice with limited histopathological consequences. EMBO J. 13:1994;4251-4259.
16. Shi S.-R., Imam S.A., Young L., Cote R.J., Taylor C.R. Antigen retrieval immunohistochemistry under the influence of pH using monoclonal antibodies. J. Histochem. Cytochem. 43:1995;193-201.
17. Geradts J., Hu S.-X., Lincoln C.E., Benedict W.F., Xu H.-J. Aberrant RB gene expression in routinely processed, archival tumor tissues determined by three different anti-RB antibodies. Int. J. Cancer. 58:1994;161-167.
18. Thapar K., Kovacs K., Scheithauer B.W., Stefaneau L., Horvath E., Pernicone P.J., Murray D., Laws E.R. Proliferative activity and invasiveness among pituitary adenomas and carcinomas: an analysis using the MIB-1 antibody. Neurosurgery. 38:1996;99-107.
19. Cartwright D.M., Miller T.R., Nasr A.J. Fine-needle aspiration biopsy of pituitary carcinoma with cervical lymph node metastases: a report of two cases and review of the literature. Diag. Cytopath. 11:1994;68-73.
20. Frost A.R., Tenner S., Tenner M., Rollhauser C., Tabbara S.O. ACTH-producing pituitary carcinoma presenting as the cauda equina syndrome. Arch. Pathol. Lab. Med. 119:1995;93-96.
21. Gollard R., Kosty M., Cheney C., Copeland B., Bordin G. Prolactin-secreting pituitary carcinoma with implants in the cheek pouch and metastases to the ovaries. Cancer. 76:1995;1814-1820.
22. Jamjoom A., Moss T., Coakham H., Jamjoom Z.A., Anthony P. Cervical lymph nodes metastases from a pituitary carcinoma. Br. J. Neurosurg. 8:1994;87-92.
23. Pegolo G., Buckwalter J.G., Weiss M.H., Hinton D.R. Pituitary adenomas. Correlation of the cytologic appearance with biologic behavior. Acta Cytologica. 39:1995;887-892.
24. Alvaro V., Levy L., Dubray C., Roche A., Peillon F., Querat B., Joubert D. Invasive human pituitary tumors express a point-mutated α-protein kinase-C. J. Clin. Endocrinol. Metab. 77:1993;1125-1129.
25. Lucke M., Hamel W., Ludecke D.K., Herrmann H.-D., Westphal H.M. Expression of retinoblastoma gene in human intracranial neoplasms. Int. J. Oncol. 4:1994;885-890.
26. Woloschak M., Roberts J.L., Post K.D. Loss of heterozygosity at the retinoblastoma locus in human pituitary tumors. Cancer. 74:1994;693-696.
27. Cryns V.L., Alexander J.M., Klibanski A., Arnold A. The retinoblastoma gene in human pituitary tumors. J. Clin. Endocrinol. Metab. 77:1993;644-646.
28. Pei L., Melmed S., Scheithauer B., Kovacs K., Benedict W.F., Prager D. Frequent loss of heterozygosity at the retinoblastoma susceptibility gene (RB) locus in aggressive pituitary tumors: evidence for a chromosome 13 tumor suppressor gene other than RB. Cancer Res. 55:1995;1613-1616.
29. Molinatti P.A., Scheithauer B.W., Randall R.V., Laws E.R. Jr. Metastasis to pituitary adenoma. Arch. Pathol. Lab. Med. 109:1985;287-289.
30. Post K.D., McKormick P.C., Hays A.P., Kandhi A.G. Metastatic carcinoma to pituitary adenoma: report of two cases. Surg. Neurol. 30:1988;286-292.
31. Ramsay J.A., Kovacs K., Scheithauer B.W., Ezrin C., Weiss M.H. Metastatic carcinoma to pituitary adenomas: a report of two cases. Exp. Clin. Endocrinol. 92:1988;69-76.
32. Verhelst J., Vanden-Broucke P., Dua G., Joosens E., Abs R., Verlooy J., Mahler C. Pituitary metastasis mimicking a pituitary adenoma. A description of two cases. Acta Clinical Belgica. 50:1995;31-35.
33. Templeton D.J., Park S.H., Lanier L., Weinberg R.A. Nonfunctional mutants of the retinoblastoma protein are characterized by defects in phosphorylation, viral protein association and nuclear tethering. Proc. Natl. Acad. Sci. USA. 88:1991;3033-3037.